Monument Capital Management Makes New $252,000 Investment in National Health Investors, Inc. $NHI

Key Points

• Monument Capital Management has made a new investment of approximately $252,000 in National Health Investors, Inc. (NHI), acquiring 3,587 shares during the second quarter.
• National Health Investors recently reported earnings of $1.22 per share, surpassing the consensus estimate, and announced an increased quarterly dividend of $0.92 per share, resulting in a 5.0% dividend yield.
• Brokerages have recently upgraded their ratings on National Health Investors, with a consensus rating of "Buy" and an average price target of $84.83.

Monument Capital Management purchased a new position in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 3,587 shares of the real estate investment trust's stock, valued at approximately $252,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of NHI. Smartleaf Asset Management LLC lifted its holdings in shares of National Health Investors by 49.8% in the 1st quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust's stock worth $33,000 after purchasing an additional 147 shares in the last quarter. M&T Bank Corp lifted its holdings in shares of National Health Investors by 4.4% in the 1st quarter. M&T Bank Corp now owns 3,969 shares of the real estate investment trust's stock worth $293,000 after purchasing an additional 168 shares in the last quarter. Vident Advisory LLC lifted its holdings in shares of National Health Investors by 1.6% in the 1st quarter. Vident Advisory LLC now owns 12,691 shares of the real estate investment trust's stock worth $938,000 after purchasing an additional 201 shares in the last quarter. Xponance Inc. lifted its holdings in shares of National Health Investors by 11.2% in the 1st quarter. Xponance Inc. now owns 3,334 shares of the real estate investment trust's stock worth $246,000 after purchasing an additional 337 shares in the last quarter. Finally, NewEdge Advisors LLC lifted its holdings in shares of National Health Investors by 28.7% in the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust's stock worth $114,000 after purchasing an additional 345 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Trading Down 0.1%

Shares of National Health Investors stock opened at $73.75 on Friday. National Health Investors, Inc. has a 1 year low of $65.13 and a 1 year high of $82.32. The firm has a market cap of $3.50 billion, a PE ratio of 23.56, a P/E/G ratio of 3.37 and a beta of 0.77. The stock has a fifty day moving average price of $77.07 and a 200-day moving average price of $74.11. The company has a debt-to-equity ratio of 0.75, a current ratio of 10.91 and a quick ratio of 10.91.

National Health Investors (NYSE:NHI - Get Free Report) last announced its earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.06. The firm had revenue of $70.27 million during the quarter, compared to analyst estimates of $86.46 million. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The business's revenue was up 6.7% compared to the same quarter last year. During the same period last year, the firm posted $1.18 EPS. Equities research analysts anticipate that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 5.0%. The ex-dividend date is Tuesday, September 30th. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. National Health Investors's dividend payout ratio is currently 117.57%.

Analyst Ratings Changes

A number of brokerages recently issued reports on NHI. Wedbush upgraded National Health Investors to a "strong-buy" rating in a report on Wednesday, July 2nd. KeyCorp raised National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price target for the company in a research report on Thursday, July 10th. Weiss Ratings reissued a "buy (b-)" rating on shares of National Health Investors in a research report on Wednesday. Truist Financial increased their price target on National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a research report on Friday, August 15th. Finally, Wells Fargo & Company raised their target price on National Health Investors from $76.00 to $80.00 and gave the company an "equal weight" rating in a research report on Wednesday, August 27th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $84.83.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.